{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363107370103434624.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1056/nejmoa1305224"}},{"identifier":{"@type":"URI","@value":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1305224"}}],"dc:title":[{"@value":"Romosozumab in Postmenopausal Women with Low Bone Mineral Density"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383107370103434625","@type":"Researcher","foaf:name":[{"@value":"Michael R. McClung"}]},{"@id":"https://cir.nii.ac.jp/crid/1383107370103434629","@type":"Researcher","foaf:name":[{"@value":"Andreas Grauer"}]},{"@id":"https://cir.nii.ac.jp/crid/1383107370103434504","@type":"Researcher","foaf:name":[{"@value":"Steven Boonen"}]},{"@id":"https://cir.nii.ac.jp/crid/1383107370103434628","@type":"Researcher","foaf:name":[{"@value":"Michael A. Bolognese"}]},{"@id":"https://cir.nii.ac.jp/crid/1383107370103434498","@type":"Researcher","foaf:name":[{"@value":"Jacques P. Brown"}]},{"@id":"https://cir.nii.ac.jp/crid/1383107370103434626","@type":"Researcher","foaf:name":[{"@value":"Adolfo Diez-Perez"}]},{"@id":"https://cir.nii.ac.jp/crid/1383107370103434499","@type":"Researcher","foaf:name":[{"@value":"Bente L. Langdahl"}]},{"@id":"https://cir.nii.ac.jp/crid/1383107370103434502","@type":"Researcher","foaf:name":[{"@value":"Jean-Yves Reginster"}]},{"@id":"https://cir.nii.ac.jp/crid/1383107370103434624","@type":"Researcher","foaf:name":[{"@value":"Jose R. Zanchetta"}]},{"@id":"https://cir.nii.ac.jp/crid/1383107370103434497","@type":"Researcher","foaf:name":[{"@value":"Scott M. Wasserman"}]},{"@id":"https://cir.nii.ac.jp/crid/1383107370103434496","@type":"Researcher","foaf:name":[{"@value":"Leonid Katz"}]},{"@id":"https://cir.nii.ac.jp/crid/1383107370103434500","@type":"Researcher","foaf:name":[{"@value":"Judy Maddox"}]},{"@id":"https://cir.nii.ac.jp/crid/1383107370103434503","@type":"Researcher","foaf:name":[{"@value":"Yu-Ching Yang"}]},{"@id":"https://cir.nii.ac.jp/crid/1383107370103434627","@type":"Researcher","foaf:name":[{"@value":"Cesar Libanati"}]},{"@id":"https://cir.nii.ac.jp/crid/1383107370103434501","@type":"Researcher","foaf:name":[{"@value":"Henry G. Bone"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00284793"},{"@type":"EISSN","@value":"15334406"}],"prism:publicationName":[{"@value":"New England Journal of Medicine"}],"dc:publisher":[{"@value":"Massachusetts Medical Society"}],"prism:publicationDate":"2014-01-30","prism:volume":"370","prism:number":"5","prism:startingPage":"412","prism:endingPage":"420"},"reviewed":"false","url":[{"@id":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1305224"}],"createdAt":"2014-01-01","modifiedAt":"2019-08-05","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050299693922699264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of prior osteoporosis treatment on 12-month treatment response of romosozumab in patients with postmenopausal osteoporosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1050581168899409408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of prior osteoporosis treatment on early treatment response of romosozumab in patients with postmenopausal osteoporosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1050862643875914752","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"An investigation of the differential therapeutic effects of romosozumab on postmenopausal osteoporosis patients with or without rheumatoid arthritis complications: a case–control study"}]},{"@id":"https://cir.nii.ac.jp/crid/1050862643876117760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of prior osteoporosis treatment on the treatment response of romosozumab followed by denosumab in patients with postmenopausal osteoporosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002218837406720","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Role of Osteocyte-PDL Crosstalk in Tooth Movement via SOST/Sclerostin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004231168331264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706994973440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Successful induction of sclerostin in human-derived fibroblasts by 4 transcription factors and its regulation by parathyroid hormone, hypoxia, and prostaglandin E2"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707280069504","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The temporospatial pattern of energy metabolism coordinates the interactions between the bones and other organ systems"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617631708800","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Randomized head-to-head comparison of minodronic acid and raloxifene for fracture incidence in postmenopausal Japanese women: the Japanese Osteoporosis Intervention Trial (JOINT)-04"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298336570743936","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Positive and Negative Regulators of Sclerostin Expression"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306905172604032","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of Efficacy of Romosozumab With Denosumab and Risedronate in Patients Newly Initiating Glucocorticoid Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183941602304","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Loss of cyclin-dependent kinase 1 impairs bone formation, but does not affect the bone-anabolic effects of parathyroid hormone"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567187830181120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588380605884288","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Osteoporosis and Rheumatoid Arthritis: Mechanisms Underlying Osteoclast Differentiation and Activation or Factors Associated with Hip Fractures"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588381051838080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Romosozumab versus bisphosphonates for preventing subsequent vertebral fractures after balloon kyphoplasty: comparison using data from two prospective multicenter studies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846639505846912","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848658468423296","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Smad4 is required to inhibit osteoclastogenesis and maintain bone mass"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593718873472","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The diverse origin of bone-forming osteoblasts"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861287053011456","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Role of Bone-Derived Hormones in Glucose Metabolism, Diabetic Kidney Disease, and Cardiovascular Disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861705556388352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Evaluation of the efficacy and safety of romosozumab (evenity) for the treatment of osteoporotic vertebral compression fracture in postmenopausal women: A systematic review and meta‐analysis of randomized controlled trials (<scp>CDM‐J</scp>)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861705572542080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1364227868958438656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Molecular-Based Treatment Strategies for Osteoporosis: A Literature Review"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205414779520","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Wnt signals and bone metabolism"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679252417792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"『骨形成促進薬の開発に向けた新たな戦略』　副甲状腺ホルモン，リチウム，ケンパウロン"},{"@language":"en","@value":"Novel strategies for the development of anabolic agents for treatment of osteoporosis"},{"@language":"ja-Kana","@value":"ホネ ケイセイ ソクシンヤク ノ カイハツ ニ ムケタ アラタ ナ センリャク : フクコウジョウセン ホルモン,リチウム,ケンパウロン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390304704715441920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"高齢者へ最適な骨粗鬆症治療薬の使い方"},{"@language":"en","@value":"Treatment of osteoporosis for older adults"}]},{"@id":"https://cir.nii.ac.jp/crid/1390571503513892608","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"当院における骨粗鬆症患者に対するロモソズマブの治療成績"}]},{"@id":"https://cir.nii.ac.jp/crid/1390575495614979968","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"当院におけるロモソズマブの使用経験"}]},{"@id":"https://cir.nii.ac.jp/crid/1390848250124766720","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pharmacological characteristics and clinical study results of romosozumab (EVENITY<sup>®</sup>; genetical recombination), a drug with novel mechanism of action to treat osteoporosis at high risk of fracture"},{"@language":"ja","@value":"新規作用機序を有する骨粗鬆症治療薬ロモソズマブ（遺伝子組換え）（イベニティ<sup>®</sup>）の薬理学的特徴と臨床試験成績"},{"@value":"新薬紹介総説 新規作用機序を有する骨粗鬆症治療薬ロモソズマブ(遺伝子組換え)(イベニティ)の薬理学的特徴と臨床試験成績"},{"@language":"ja-Kana","@value":"シンヤク ショウカイ ソウセツ シンキ サヨウ キジョ オ ユウスル コツソショウショウ チリョウヤク ロモソズマブ(イデンシ クミカエ)(イベニティ)ノ ヤクリガクテキ トクチョウ ト リンショウ シケン セイセキ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390852405228437120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Histochemical characteristics on minimodeling-based bone formation induced by anabolic drugs for osteoporotic treatment"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1056/nejmoa1305224"},{"@type":"CROSSREF","@value":"10.1177/0022034518771331_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1007/s00198-014-2934-8_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1254/fpj.20007_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1016/j.bone.2020.115574_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.5035/nishiseisai.71.558_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.3143/geriatrics.62.117_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.2220/biomedres.42.161_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.5035/nishiseisai.70.541_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1080/03007995.2020.1816537_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1007/s00198-022-06386-y_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.3390/ijms23094895_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1210/clinem/dgae810_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1074/jbc.ra118.004834_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1517/13543784.2016.1142972_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.7600/jpfsm.3.341_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1016/j.jbspin.2021.105219_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.3390/jcm14041138_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1093/jbmrpl/ziae137_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1002/jbmr.3427_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1038/srep35221_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1002/jbmr.4410_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.3390/ijms23042376_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1002/pds.5594_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1007/s00198-022-06642-1_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1007/s00198-024-07019-2_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1016/j.job.2017.11.001_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1254/fpj.144.277_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.1016/j.bone.2016.01.024_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"},{"@type":"CROSSREF","@value":"10.3390/ijms20102557_references_DOI_N0kQ8RYkm5PqAKVAED55hBKKXEE"}]}